Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...
Benzinga.com5d
Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
Pfizer's legal win invalidates two GSK patents in UK RSV vaccine case. On Monday, Pfizer Inc. PFE stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro.
Daily Mail4d
Pfizer and BioNTech win Covid vaccine court battle to have jab patents from rival firm revoked
The two companies brought legal action over a repeated sequence in the messenger RNA (mRNA) used in CureVac's patents in life-saving coronavirus jabs. Lawyers for Pfizer and BioNTech claimed that ...
Pfizer Raises $3.2 Billion by Selling Part of Haleon Stake
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health ...
Haleon buys back £230m of its shares as Pfizer sells down stake
Pfizer has offloaded a £2.43billion stake in consumer health spin-out Haleon, which said it would buy back £230million of the ...
Why Pfizer Will Find It Hard to Appease Its Activist Investor
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Bloomberg L.P.13d
Pfizer Set to Raise £2.7 Billion From Haleon Stake Sale
Pfizer Inc. is poised to raise about £2.7 billion ($3.6 billion) from the sale of Haleon Plc shares, as it further reduces its stake in the UK consumer health giant. The US company increased the ...
ENDPOINTS NEWS1d
Lil­ly fol­lows the trend of new AI hires; Pfiz­er fills key UK po­si­tion as ac­tivist hub­bub swells
Eli Lilly has joined the club of pharma companies that have lined up AI execs. Thomas Fuchs will be Lilly’s first-ever chief ...